Company performance
Add to research
Current Price
as of Apr 21, 2025$2.01
P/E Ratio
N/A
Market Cap
$152.39M
Description
Add to research
Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.
Metrics
Add to research
Overview
- HQBala Cynwyd, PA
- SectorHealth Technology
- IndustryBiotechnology
- TickerLRMR
- Price$2.01+5.24%
Trading Information
- Market cap$152.39M
- Float57.29%
- Average Daily Volume (1m)1,089,950
- Average Daily Volume (3m)807,819
- EPS-$1.32
Company
- RevenueN/A
- Rev growth (1yr)N/A
- Net income-$80.60M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$90.57M
- EV$58.72M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
- P/B0.88
- Debt/Equity2.98
Documents
Add to research
SEC Filings